A comprehensive view of f. hoffmann-la roche ltd. (roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Roche Expands Cancer Care in Taiwan through TTY Biopharm Collaboration and Drives Women's Health Initiatives with #MyStoryForChange Campaign
Published:
March 27, 2024
by Industry Intelligence Inc.
|
Chugai: Piasky (crovalimab) for Paroxysmal Nocturnal Hemoglobinuria approved in Japan
Published:
March 26, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Roche receives FDA approval for the first molecular test to screen for malaria in blood donors
Published:
March 26, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
FDA approves Roche's cobas Malaria test for use on the cobas 6800/8800 Systems, making it the first molecular test for malaria screening in US; malaria affected about 292 million people in 2022, with Africa accounting for 94% of cases
Published:
March 26, 2024
by GlobeNewswire Europe
|
Roche Bolsters Neurodegeneration Research and Diagnostic Innovation with Top-tier Talent and Next-gen Reagents
Published:
March 25, 2024
by Industry Intelligence Inc.
|
Ask us about our Health Care Sector market view